Bucharest, Romania – [28 May 2025] – ZayaAI, a leading provider of AI-powered digital pathology solutions, is excited to announce a collaboration with Mindpeak, an international leader in AI powered cancer diagnostics. The collaboration will see Mindpeak’s AI suites for Breast Cancer, Prostate Cancer, and PD-L1 biomarker analysis fully integrated into ZayaAI’s Laboratory Information System (LIS) platform, enhancing diagnostic workflows for laboratories and hospitals globally.
This integration empowers pathologists using ZayaAI’s digital platform with instant access to Mindpeak’s CE-IVD approved and clinically validated AI models, offering precise and reproducible detection, quantification, and scoring of relevant cancer features in whole slide images (WSI). The inclusion of PD-L1, a key biomarker in immunotherapy, further strengthens the clinical utility of the combined platform.
Cristian Mogodici, CEO of ZayaAI, stated:
“At ZayaAI, we’re building a scalable and accessible diagnostic platform that brings the best AI tools directly into the pathologist’s workflow. Mindpeak’s breast, prostate, and PD-L1 AI suites are powerful additions that align with our mission to democratize advanced pathology diagnostics. We are thrilled to offer these capabilities within our LIS ecosystem to enhance both accuracy and efficiency across use cases.”
Felix Faber, CEO of Mindpeak, added:
“We’re proud to partner with ZayaAI to bring our high-performance cancer diagnostics and biomarker scoring tools to more laboratories worldwide. Their comprehensive digital pathology platform is an ideal environment for the deployment of our models, and this collaboration supports our mission to make AI-supported pathology a global standard.”
The new joint offering is available immediately to ZayaAI’s clients and will be showcased during upcoming international pathology and digital health conferences.
About ZayaAI
ZayaAI offers a next-generation digital pathology platform integrating a cloud-based LIS, telepathology, and embedded AI diagnostics. Its solutions are designed for scalability, compliance, and ease of use in both emerging markets and advanced clinical settings. Learn more at www.zaya.ai and LinkedIn
About Mindpeak
Founded in 2018, Mindpeak is a global innovator in AI-driven digital pathology solutions. The company develops cutting-edge algorithms that support pathologists in routine diagnostics, focusing on automating tissue analysis for faster, more accurate results. Mindpeak’s platform is designed to enhance productivity and diagnostic confidence in clinical labs, helping to improve patient outcomes in cancer care. For more information, visit www.mindpeak.ai and LinkedIn.